文献速递炎症性肠病

乳糜泻与炎症性肠病并存的病例对照研究

Case-control study of the concurrence of coeliac disease with inflammatory bowel disease.
PubMed 文献 · Aliment Pharmacol Ther · 2023-02-02

基于美国Inform Diagnostics组织病理学数据库的病例对照研究,在双向内镜检查患者中比较乳糜泻在炎症性肠病(IBD)或显微镜下结肠炎(MC)患者与无炎症性结肠炎对照中的发生率。结果显示IBD患者乳糜泻患病率0.4%(57/12816)低于对照的0.7%(2548/345733),OR为0.50(95%CI 0.38-0.64);MC患者患病率4.4%(288/6486),OR为6.78(95%CI 5.96-7.69)。作者认为既往报告的乳糜泻与IBD正相关可能因将MC病例纳入IBD人群而产生偏倚。

要点

  • IBD患者乳糜泻患病率0.4%(57/12816),低于无结肠炎对照的0.7%(2548/345733)。
  • 校正年龄、性别和种族分布后,IBD患者乳糜泻OR为0.50(95%CI 0.38-0.64)。
  • MC患者乳糜泻患病率4.4%(288/6486),OR为6.78(95%CI 5.96-7.69)。

核心结论

  • 既往报告的乳糜泻与IBD正相关可能因将MC病例纳入IBD人群而产生偏倚。

研究设计与样本

  • 病例对照研究,使用美国Inform Diagnostics组织病理学数据库,纳入双向内镜检查患者。
  • 比较IBD或MC病例与无炎症性结肠炎对照的乳糜泻发生情况,计算校正年龄、性别和种族分布的OR及95%CI。
  • 研究人群包括12816例IBD病例、6486例MC病例和345733例无结肠炎对照。
  • 共2892例患者诊断为乳糜泻。

主要发现

  • IBD患者中57例(0.4%)患乳糜泻,对照人群为0.7%(2548/345733)。
  • MC患者中乳糜泻患病率为4.4%(288/6486)。
  • IBD患者乳糜泻OR为0.50(95%CI 0.38-0.64),显著降低。
  • MC患者乳糜泻OR为6.78(95%CI 5.96-7.69),显著升高。
  • 按IBD亚型(克罗恩病或溃疡性结肠炎)和MC亚型(胶原性或淋巴细胞性结肠炎)分层后,各亚型OR仍分别显著降低和升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Previous studies suggested that inflammatory bowel disease (IBD) is associated with an increased prevalence of comorbid coeliac disease. Our case-control study aimed to test this association using a large histopathology database. METHODS: The Inform Diagnostics database is a repository of histopathologic records from patients distributed throughout the United States. In a case-control study among patients with bidirectional endoscopy, we compared the occurrence of coeliac disease in case subjects with IBD or microscopic colitis (MC) and control subjects without inflammatory colitis, calculating odds ratios (OR) and their 95% confidence intervals (CI) adjusted to the varying age, gender and ethnic distributions of case and control subjects. RESULTS: The study population was split into 12,816 IBD cases and 6486 MC cases, who were compared to 345,733 control subjects without colitis. A total of 2892 patients were diagnosed with coeliac disease. Of 12,816 IBD patients, 57 patients (0.4%) harboured coeliac disease compared to 0.7% (2548/345,733) in the control population. The prevalence of coeliac disease among MC patients was 4.4% (288/6486). The corresponding ORs were significantly decreased in IBD (OR: 0.50, CI: 0.38-0.64) and significantly increased in MC patients (6.78, 5.96-7.69). Further stratification of the case populations into subtypes of IBD (Crohn's disease or ulcerative colitis) and MC (collagenous or lymphocytic colitis) similarly revealed significantly decreased and increased ORs for each subtype. CONCLUSIONS: The previously reported positive association between coeliac disease and IBD may have been possibly biased by the inclusion of MC cases in the IBD patient population.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Sonnenberg A, Genta RM. Case-control study of the concurrence of coeliac disease with inflammatory bowel disease. Aliment Pharmacol Ther. 2023. PMID: 36727466. doi:10.1111/apt.17408

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。